Comparative effectiveness of drugs used to constrict the patent ductus arteriosus: a secondary analysis of the PDA-TOLERATE trial (NCT01958320)


Creative Commons License

Liebowitz M., Kaempf J., ERDEVE Ö., Bulbul A., Hakansson S., Lindqvist J., ...Daha Fazla

JOURNAL OF PERINATOLOGY, cilt.39, sa.5, ss.599-607, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

Özet

Objective To evaluate the effectiveness of drugs used to constrict patent ductus arteriosus (PDA) in newborns < 28 weeks.